Cue Biopharma (CUE) Return on Assets [ROA] (2018 - 2026)
Cue Biopharma's Return on Assets [ROA] was -279.62% in Q2 2026, down 154.52 percentage points from -125.10% a year earlier.
Powered by 
Analysis
Cue Biopharma (CUE) Return on Assets [ROA] (2018 - 2026) Analysis & Trends
For FY2025, Return on Assets [ROA] at Cue Biopharma came in at -72.72%, up 15.84 percentage points from FY2024.
- Return on Assets [ROA] shows a five-year change of -20.38 percentage points (FY2020 to FY2025).
- In earlier years, Return on Assets [ROA] was -88.56% in FY2024 (-20.31 pp), -68.25% in FY2023 (-7.56 pp), -60.69% in FY2022 (-12.41 pp) and -48.28% in FY2021 (+4.06 pp).
- The Q2 2026 figure marks the lowest quarterly Return on Assets [ROA] in data going back to Q1 2018.
- Compared with a year earlier, Return on Assets [ROA] was higher in 1 of the last seven quarters, with an average year-over-year change of -37.69 percentage points.
- The best year-over-year quarter for Return on Assets [ROA] over five years was Q4 2025 (a gain of 35.89 percentage points); the worst was Q2 2026 (a drop of 154.52 percentage points).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,137.66 Bn | 1,106.24 Bn | 19.71 Bn | 20.64% |
| 2 | Johnson & Johnson | 636.13 Bn | 556.00 Bn | 17.30 Bn | 8.08% |
| 3 | AbbVie | 505.28 Bn | 478.39 Bn | 12.70 Bn | 4.65% |
| 4 | Merck | 358.10 Bn | 312.48 Bn | 12.21 Bn | 2.45% |
| 5 | Novartis Ag | 292.59 Bn | 256.58 Bn | 11.24 Bn | 10.60% |
| 6 | Astrazeneca | 265.81 Bn | 239.50 Bn | 12.86 Bn | 9.10% |
| 7 | Amgen | 237.53 Bn | 192.93 Bn | 7.24 Bn | 9.29% |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | -6.13% |
| 9 | Pfizer | 171.17 Bn | 117.82 Bn | 10.94 Bn | 2.14% |
| 10 | Cue Biopharma | 117.65 Mn | 26.93 Mn | - | -279.62% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -279.62% |
| Dec 31, 2025 | -71.90% |
| Sep 30, 2025 | -105.49% |
| Jun 30, 2025 | -125.10% |
| Mar 31, 2025 | -151.09% |
| Dec 31, 2024 | -107.79% |
| Sep 30, 2024 | -104.89% |
| Jun 30, 2024 | -100.34% |
| Mar 31, 2024 | -89.08% |
| Dec 31, 2023 | -79.97% |
| Sep 30, 2023 | -74.88% |
| Jun 30, 2023 | -68.35% |
| Mar 31, 2023 | -60.93% |
| Dec 31, 2022 | -63.94% |
| Sep 30, 2022 | -57.88% |
| Jun 30, 2022 | -55.25% |
| Mar 31, 2022 | -52.24% |
| Dec 31, 2021 | -53.90% |
| Sep 30, 2021 | -55.46% |
| Jun 30, 2021 | -49.05% |
API Access
Cue Biopharma Return on Assets [ROA] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=CUE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-assets-[roa]", "ticker": "CUE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=CUE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();